Canton Strategic Holdings (CNTN) Notes Payables (2020 - 2025)

Canton Strategic Holdings (CNTN) reported Notes Payables of $161117.0 for Q3 2025, down 35.48% quarter-over-quarter from $249716.0 in Q2 2025.

Canton Strategic Holdings (CNTN) Notes Payables (2020 - 2025) Analysis & Trends

Canton Strategic Holdings has reported Notes Payables for 3 years, with the latest figure at $161117.0 in Q3 2025.

For the quarter ending Q3 2025, Notes Payables changed N/A year-over-year to $161117.0; the trailing twelve-month figure through Sep 2025 stood at $161117.0 (changed N/A YoY), and the FY2021 full-year result was $1.4 million, up 147.16% from the prior year.
Notes Payables for Q3 2025 stood at $161117.0, down from $249716.0 in the prior quarter.
The five-year high for Notes Payables was $1.4 million in Q4 2021, with the low at $161117.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Canton Strategic Holdings	699.97 Mn	658.44 Mn	-

Download Data